Navigation Links
DURECT Corporation Invites You to Join Its Fourth Quarter 2007 Earnings Conference Call
Date:1/31/2008

CUPERTINO, Calif., Jan. 31 /PRNewswire-FirstCall/ -- In conjunction with DURECT Corporation's (Nasdaq: DRRX) fourth quarter 2007 financial results press release, you are invited to listen to the conference call that will be broadcast live over the Internet on Wednesday, February 6, 2008 at 9:00 a.m. EST (6:00 a.m. PST).

When: Wednesday, February 6, 2008 at 9:00 a.m. EST (6:00 a.m. PST).

Where: Live over the Internet -- Simply log on to http://www.durect.com,

and then click 'Investor Relations' and then 'Events Calendar.'

Webcast

Link: http://phx.corporate-ir.net/phoenix.zhtml?c=121590&p=irol-calendar

If you are unable to participate during the live webcast, the call will be archived on DURECT's website under Audio Archive in the "Investor Relations" section.

About DURECT Corporation

DURECT Corporation is an emerging specialty pharmaceutical company developing pharmaceutical systems based on its proprietary drug delivery platform technologies. The Company currently has a number of late-stage pharmaceutical products in development addressing large markets in pain management, with a number of research programs underway targeting chronic disease and other therapeutic areas. For more information, please visit http://www.durect.com.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020717/DRRXLOGO)


'/>"/>
SOURCE DURECT Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. DURECT to Host Webcast in Conjunction with an Analysts Day on October 17
2. DURECT Corporation to Present at the NewsMakers in the Biotech Industry Investment Conference
3. Baxa Corporation Launches New Web Site
4. CuraGen Corporation Receives Notification from NASDAQ
5. Healionics Corporation Completes Series A Financing
6. Techne Corporation Releases Unaudited Second Quarter Results for Fiscal Year 2008
7. China Bionanometer Industries Corporation Announces Record Second Quarter 2007 Results
8. Hagens Berman Sobol Shapiro: Lawsuit Filed Against CellCyte Genetics Corporation
9. Sigma-Aldrich Corporations 4th Quarter 2007 Earnings Conference Call
10. Omeros Corporation Files Registration Statement for Proposed Initial Public Offering
11. Genelex Corporation Defends Consumers Right to Obtain DNA Information:
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... ... July 30, 2015 , ... ... Vieillard as Sales & Marketing Director. , With more than 25 years ... responsible for reinforcing Tronics’ business development activities worldwide. He brings to the company ...
(Date:7/30/2015)... , ... July 30, 2015 , ... ... of a field clinical study of its canine osteoarthritis stem cell product, currently ... Therapeutics (Kansas City, KS) and will be marketed in the US by Aratana. ...
(Date:7/30/2015)... across the globe, ISN improves the efficiency and effectiveness of contractor management systems. ISN,s ... reliable contractors in over 80 countries. ... ... Over 60,000 Worldwide Customers In More Than 80 Countries ... Headquartered in Dallas, TX , ISN has additional offices in Calgary ...
(Date:7/30/2015)... Pa. , July 30, 2015  Discovery ... that it has received the second $1.0M tranche ... Innovation Research (SBIR) grant valued at up to ... company,s aerosolized KL4 surfactant as a potential medical ... injury.  Discovery Labs was awarded an initial $1.0 ...
Breaking Biology Technology:Tronics appoints Francois Vieillard as Sales and Marketing Director 2VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 2VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 3ISN Reaches Over 60,000 Worldwide Customers 2ISN Reaches Over 60,000 Worldwide Customers 3Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 2Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 3
... Cornelius, CEO of Bristol-Myers Squibb, MALVERN, ... an,emerging specialty pharmaceutical company focused on improving ... commercialization of treatments,for diseased and aging skin ... President and Chief Executive Officer, will be,presenting ...
... Fla., Oct. 19 An affiliate of,Phlo ... today that,the distribution of its vitality product, ... system-wide coverage within Northern California and has,been ... the,Palm Desert/Palm Springs area. In Northern ...
... BioWa, Inc. (BioWa) announced,today that it ... provides,GlaxoSmithkline (GSK) with access to BioWa,s patented ... cellular,cytotoxicity (ADCC) enhanced antibodies. The agreement ... develop,antibodies based on POTELLIGENT(R) Technology for an ...
Cached Biology Technology:Cutanea to Present at the Paramount BioSciences Healthcare Conference 2AQUISS Continues Expansion Into New Territory 2BioWa Announces Licensing of BioWa's POTELLIGENT(R) Technology by GlaxoSmithkline for Use in Antibody Research and Development 2
(Date:7/7/2015)... VIEW, Calif. , July 7, 2015 /PRNewswire/ ... biometrics market, Frost & Sullivan recognizes Credence ID, ... Sullivan Entrepreneurial Company of the Year Award. ... suite to aid in its mission of offering ... under-recognized populations globally. As Credence ID was formed ...
(Date:7/2/2015)... 25, 2015 Research and ... "Next Generation Biometrics Market by Application, Technology, Function ... to their offering. The next generation biometrics ... at a CAGR of 17.9% between 2015 and 2020 ... for the market. Safran SA ( ...
(Date:6/30/2015)... Genisphere announced Tom Bliss ... further develop Genisphere,s therapeutics capabilities and portfolio. Mr. Bliss ... much of the last 25 years in leadership positions ... Johnson & Johnson. Tom started his career in Investment ... Finance. He graduated from Dartmouth College with a BA ...
Breaking Biology News(10 mins):Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 2Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 5Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 2Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 3Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3
... women to participate in the first U.S. study of the safety ... HIV infection. , If it is effective and approved by the ... weapon in the fight against HIV because it would allow women ... to use condoms. , "The significance of the gel is ...
... have visualized in a living animal how cells use a ... create unique and varied proteins. , The scientists say the ... human biology: how the same genes found in every cell ... tissues and organs. These varied proteins, in turn, dictate the ...
... Scientists at the University of Michigan Medical School have ... form of kidney disease and renal failure in children: ... or PLCE1. , Identifying the mutant gene is important ... ?specialized cells that play a vital role in the ...
Cached Biology News:UCSF study will test new vaginal microbicide for herpes and HIV 2UCSF study will test new vaginal microbicide for herpes and HIV 3Living view in animals shows how cells decide to make proteins 2Living view in animals shows how cells decide to make proteins 3Mutant gene causes severe kidney disease in infants 2Mutant gene causes severe kidney disease in infants 3Mutant gene causes severe kidney disease in infants 4
Request Info...
Molecular Biological Resources has extensive abilities cloning and expression of prokaryotic and eukaryotic proteins. Please contact lloconne@molbiores.com to discuss your project. Contact lloconne@...
Lentigen's manufacturing platform is sufficiently versatile for use in the manufacture of any HIV-based Lentiviral vector. Lentigen will manufacture your LV of choice to the highest possible titer a...
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Biology Products: